Cover Image

Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME ( US ) study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Dawn C. Buse, E. Jolanda Muenzel, Anthony J. Zagar, Ali Sheikhi Mehrabadi, Robert E. Shapiro, Gilwan Kim, Sait Ashina, Robert A. Nicholson, Richard B. Lipton
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Headache: The Journal of Head and Face Pain
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Unmet treatment needs in migraine: Results of the OVERCOME (US) study
by: Susan Hutchinson, et al.
Published: (2026)

Development of the Migraine‐Related Stigma (MiRS) Questionnaire: Results of the OVERCOME (US) Study
by: Elizabeth K. Seng, et al.
Published: (2025)

Reasons for patient reluctance to take preventive medications for migraine: Results of the OVERCOME ( US ) study
by: Jessica Ailani, et al.
Published: (2026)

Metaphorical use of “headache” and “migraine” in media: A longitudinal study of 1.3 million articles in major publications
by: Pengfei Zhang, et al.
Published: (2024)

Prevalence and burden of migraine in the United States: A systematic review
by: Fred Cohen, et al.
Published: (2024)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
by: Rikki Mangrum, et al.
Published: (2024)

Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi‐country results from the CaMEO‐I study
by: Dawn C. Buse, et al.
Published: (2024)

What a long strange trip it's been: Reflections on serial snapshots of migraine prevalence and burden in the United States
by: Fred Cohen, et al.
Published: (2025)

Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United States findings
by: Fred Cohen, et al.
Published: (2024)

Rates and healthcare resource utilization for people with branded acute and preventive migraine prescription medication order payer denials: An open, multi‐source dataset, observational cohort study
by: Dawn C. Buse, et al.
Published: (2026)

No differences in subcortical volume between people with and without migraine: A REFORM study
by: Basit Ali Chaudhry, et al.
Published: (2025)

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine
by: David Kudrow, et al.
Published: (2025)

Sex influences the progression of cephalic mechanical and light hypersensitivities in a mouse model of chronic migraine
by: Marie Raquin, et al.
Published: (2025)

Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial
by: Nathaniel M. Schuster, et al.
Published: (2025)

Comparative analysis of real‐world acute prescription migraine therapy outcomes: Insights from the HeAD – US study
by: Devin Teichrow, et al.
Published: (2026)

Correction to “Smartphone‐delivered progressive muscle relaxation for the treatment of migraine in primary care: A randomized controlled trial”
Published: (2025)

Behavioral interventions for migraine prevention: A systematic review and meta‐analysis
by: Jonathan R. Treadwell, et al.
Published: (2025)

Integrating gepants into clinical practice for the acute treatment of migraine
by: Richard B. Lipton, et al.
Published: (2026)

Real‐world barriers to health care utilization among people living with migraine: Insights from the All of Us Research Program
by: Idris Demirsoy, et al.
Published: (2025)

A 3‐year follow‐up study of outcomes associated with patterns of traditional acute and preventive migraine treatment: An administrative claims‐based cohort study in the United States
by: Shivang Joshi, et al.
Published: (2024)

The cortical spreading depression/migraine aura hypothesis – Finally some definitive evidence
by: Andrew C. Charles, et al.
Published: (2025)

Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment
by: Richard B. Lipton, et al.
Published: (2025)

Useful considerations for treating migraine in patients with autism
by: Sinifunanya E. Nwaobi
Published: (2026)

Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial
by: Anna Gryglas‐Dworak, et al.
Published: (2024)

Readability analysis and concept mapping of PROMs used for headache disorders
by: Merel H. J. Hazewinkel, et al.
Published: (2024)

Exploring the relationship between pain catastrophizing and migraine in youth: A longitudinal clinical cohort study
by: Alexis Espanioli, et al.
Published: (2025)

Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing
by: Richard B. Lipton, et al.
Published: (2025)

Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper
by: Lawrence C. Newman, et al.
Published: (2025)

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials
by: Stephen D. Silberstein, et al.
Published: (2024)

Treatment effectiveness of galcanezumab versus traditional oral migraine preventive medications at 3 months: Results from the TRIUMPH study
by: Richard B. Lipton, et al.
Published: (2025)

Rising migraine incidence in adolescents despite stable prevalence in the US : A call for further investigation
by: Ali Reza Tavasoli, et al.
Published: (2024)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
by: Graham A. McLeod, et al.
Published: (2025)

Response to: Disagreement with Categorization of Clinical Trials included in Treadwell et al. Systematic Review and Meta‐Analysis
by: Jonathan R. Treadwell, et al.
Published: (2025)

Routine migraine screening as a standard of care for Women's health: A position statement from the American Headache Society
by: Todd J. Schwedt, et al.
Published: (2025)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
by: Yunus Emre Meydanal, et al.
Published: (2025)

Reassessing pediatric migraine disability: Toward an updated assessment tool in the era of novel therapeutics
by: Ali Reza Tavasoli, et al.
Published: (2025)

Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents
by: Bilal Ahmed Rizvi, et al.
Published: (2024)

Substance use in a Dutch migraine cohort compared with the general population
by: Thomas C. van den Hoek, et al.
Published: (2024)

Evaluating associations of migraine‐related vertigo
by: Nazia Karsan, et al.
Published: (2025)

Headache‐related disability as a function of migraine aura: A daily diary study
by: Delora E. Denney, et al.
Published: (2024)